These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 35721728)
21. Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry. Hosokawa Y; Kawakita R; Yokoya S; Ogata T; Ozono K; Arisaka O; Hasegawa Y; Kusuda S; Masue M; Nishibori H; Sairenchi T; Yorifuji T Endocr J; 2017 Sep; 64(9):867-880. PubMed ID: 28701683 [TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and long-term outcome of Taiwanese children with congenital hyperinsulinism. Lee CT; Liu SY; Tung YC; Chiu PC; Wu MZ; Tsai WY J Formos Med Assoc; 2016 May; 115(5):306-10. PubMed ID: 25960244 [TBL] [Abstract][Full Text] [Related]
23. Hyperinsulinism in the Neonate. Lord K; De León DD Clin Perinatol; 2018 Mar; 45(1):61-74. PubMed ID: 29406007 [TBL] [Abstract][Full Text] [Related]
24. Bridging the gaps: recent advances in diagnosis, care, and outcomes in congenital hyperinsulinism. Rosenfeld E; De León DD Curr Opin Pediatr; 2023 Aug; 35(4):486-493. PubMed ID: 36974442 [TBL] [Abstract][Full Text] [Related]
25. Investigation and management of congenital hyperinsulinism. Gilbert C Br J Nurs; 2009 Nov 26-Dec 9; 18(21):1306-10. PubMed ID: 20081678 [TBL] [Abstract][Full Text] [Related]
26. Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset. Worth C; Tropeano Y; Gokul PR; Cosgrove KE; Salomon-Estebanez M; Senniappan S; Dastamani A; Banerjee I BMJ Open Diabetes Res Care; 2022 Jun; 10(3):. PubMed ID: 35675953 [TBL] [Abstract][Full Text] [Related]
27. Congenital hyperinsulinism: management and outcome, a single tertiary centre experience. El Tonbary K; Robinson P; Banerjee I; Shaikh MG Eur J Pediatr; 2020 Jun; 179(6):947-952. PubMed ID: 32002613 [TBL] [Abstract][Full Text] [Related]
28. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals. Yap KL; Johnson AEK; Fischer D; Kandikatla P; Deml J; Nelakuditi V; Halbach S; Jeha GS; Burrage LC; Bodamer O; Benavides VC; Lewis AM; Ellard S; Shah P; Cody D; Diaz A; Devarajan A; Truong L; Greeley SAW; De Leó-Crutchlow DD; Edmondson AC; Das S; Thornton P; Waggoner D; Del Gaudio D Genet Med; 2019 Jan; 21(1):233-242. PubMed ID: 29907798 [TBL] [Abstract][Full Text] [Related]
29. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol. Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284 [TBL] [Abstract][Full Text] [Related]
30. The Birth Prevalence of Congenital Hyperinsulinism: A Narrative Review of the Epidemiology of a Rare Disease. Lapidus D; De León DD; Thornton PS; Hood D; Breit J; Raskin J; Pasquini TLS Horm Res Paediatr; 2024 Jun; ():1-8. PubMed ID: 38885633 [TBL] [Abstract][Full Text] [Related]
31. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. Adzick NS; Thornton PS; Stanley CA; Kaye RD; Ruchelli E J Pediatr Surg; 2004 Mar; 39(3):270-5. PubMed ID: 15017536 [TBL] [Abstract][Full Text] [Related]
32. Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. Stanley CA J Clin Endocrinol Metab; 2016 Mar; 101(3):815-26. PubMed ID: 26908106 [TBL] [Abstract][Full Text] [Related]
33. Congenital hyperinsulinism: characterization of patients treated in a pediatric university hospital in Colombia. Pedraza-Flechas PV; Pereira-Ospina RP; Molinares-Mejía JS; Suescún-Vargas JM; Pinzón-Salamanca JY Bol Med Hosp Infant Mex; 2020; 77(2):94-99. PubMed ID: 32226004 [TBL] [Abstract][Full Text] [Related]
34. Genetic pathogenesis, diagnosis, and treatment of short-chain 3-hydroxyacyl-coenzyme A dehydrogenase hyperinsulinism. Zhang W; Sang YM Orphanet J Rare Dis; 2021 Nov; 16(1):467. PubMed ID: 34736508 [TBL] [Abstract][Full Text] [Related]
35. Surgical management of medically-refractory hyperinsulinism. Zobel MJ; McFarland C; Ferrera-Cook CT; Padilla BE Am J Surg; 2020 Jun; 219(6):947-951. PubMed ID: 31757439 [TBL] [Abstract][Full Text] [Related]
36. Incidence, predictors and outcomes of redo pancreatectomy in infants with congenital hyperinsulinism: a 16-year tertiary center experience. Al-Ameer A; Alsomali A; Habib Z Pediatr Surg Int; 2023 Apr; 39(1):183. PubMed ID: 37079145 [TBL] [Abstract][Full Text] [Related]
37. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor. Katz LE; Ferry RJ; Stanley CA; Collett-Solberg PF; Baker L; Cohen P J Clin Endocrinol Metab; 1999 Sep; 84(9):3117-24. PubMed ID: 10487673 [TBL] [Abstract][Full Text] [Related]
38. Health-Related Quality of Life of Children and Adolescents With Congenital Hyperinsulinism - A Scoping Review. Kristensen K; Quitmann J; Witt S Front Endocrinol (Lausanne); 2021; 12():784932. PubMed ID: 34925243 [TBL] [Abstract][Full Text] [Related]
39. Clinical Course and Outcome in Children with Congenital Hyperinsulinism. Saneifard H; Hajihashemi E; Fallahi M Arch Iran Med; 2022 Jul; 25(7):422-427. PubMed ID: 36404508 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic surgery in infants with Beckwith-Wiedemann syndrome and hyperinsulinism. Laje P; Palladino AA; Bhatti TR; States LJ; Stanley CA; Adzick NS J Pediatr Surg; 2013 Dec; 48(12):2511-6. PubMed ID: 24314195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]